Literature DB >> 44202

Changes in transglutaminase activity in an experimental model of pulmonary fibrosis induced by paraquat.

M Griffin, L L Smith, J Wynne.   

Abstract

An experimental model of pulmonary fibrosis has been developed by dosing rats with one-fifth the LD50 dose of the herbicide paraquat on 5 consecutive days. Approximately 50% of the rats died within 4 days of the completion of dosing, showing macroscopic changes and wet weight increases in the lung consistent with severe oedema. Those animals which died between Days 4 and 10 had markedly increased levels of hydroxyproline in the lung, maximum at Day 6, and increased prolyl hydroxylase activity, maximum at Day 4. These changes, together with an increase in thymidine incorporation into DNA, and increased lung DNA content, were consistent with the development of fibrosis. Measurement of transglutaminase activity in the lung showed marked increases at Days 4 and 10 after completion of dosing. This activity paralleled closely the changes in prolyl hydroxylase activity and became increasingly associated with particulate protein present in the "nuclear pellet" fraction. The presence of zymogen plasma transglutaminase trapped in lung homogenates could not be demonstrated but the contribution by the active plasma transglutaminase (Factor XIIIa) to increases shown at Day 4 cannot be ruled out.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 44202      PMCID: PMC2041575     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN: 0007-1021


  28 in total

1.  Collagen prolyl hydroxylase levels in experimental paraquat poisoning.

Authors:  W D Thompson; R S Patrick
Journal:  Br J Exp Pathol       Date:  1978-06

Review 2.  Primary pulmonary responses to toxic agents.

Authors:  H Witschi; M G Côte
Journal:  CRC Crit Rev Toxicol       Date:  1977-05

3.  Cell surface-associated structural proteins in connective tissue cells.

Authors:  P Bornstein; J F Ash
Journal:  Proc Natl Acad Sci U S A       Date:  1977-06       Impact factor: 11.205

4.  Modifications of the diphenylamine reaction giving increased sensitivity and simplicity in the estimation of DNA.

Authors:  G M Richards
Journal:  Anal Biochem       Date:  1974-02       Impact factor: 3.365

5.  The effects of bleomycin and copper bleomycin upon transglutaminase enzymes.

Authors:  M Griffin; R N Barnes; J Wynne; C Williams
Journal:  Biochem Pharmacol       Date:  1978       Impact factor: 5.858

Review 6.  Cross-linking of plasma and cellular fibronectin by plasma transglutaminase.

Authors:  D F Mosher
Journal:  Ann N Y Acad Sci       Date:  1978-06-20       Impact factor: 5.691

7.  Cellular transglutaminase, growth, and transformation.

Authors:  P J Birckbichler; M K Patterson
Journal:  Ann N Y Acad Sci       Date:  1978-06-20       Impact factor: 5.691

8.  The toxicity of paraquat.

Authors:  D G Clark; T F McElligott; E W Hurst
Journal:  Br J Ind Med       Date:  1966-04

9.  Effect of paraquat on rat lung prolyl hydroxylase.

Authors:  M A Hollinger; M Chvapil
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1977-01

10.  Differential effects of polyadenylic: polyuridylic acid and lipopolysaccharide on the generation of cytotoxic T lymphocytes.

Authors:  P R Narayanan; G Sundharadas
Journal:  J Exp Med       Date:  1978-05-01       Impact factor: 14.307

View more
  26 in total

1.  [Cross-linking in an artificial human cornea via induction of tissue transglutaminases].

Authors:  N Kopsachilis; I Tsinopoulos; K T Tsaousis; R Meiller; S A Dimitrakos; F E Kruse; U W Luessen
Journal:  Ophthalmologe       Date:  2012-06       Impact factor: 1.059

2.  A crucial sequence for transglutaminase type 2 extracellular trafficking in renal tubular epithelial cells lies in its N-terminal beta-sandwich domain.

Authors:  Che-Yi Chou; Andrew J Streets; Philip F Watson; Linghong Huang; Elisabetta A M Verderio; Timothy S Johnson
Journal:  J Biol Chem       Date:  2011-06-07       Impact factor: 5.157

3.  The role of transglutaminase in the rat subtotal nephrectomy model of renal fibrosis.

Authors:  T S Johnson; M Griffin; G L Thomas; J Skill; A Cox; B Yang; B Nicholas; P J Birckbichler; C Muchaneta-Kubara; A Meguid El Nahas
Journal:  J Clin Invest       Date:  1997-06-15       Impact factor: 14.808

4.  Transforming growth factor-beta1 mediated up-regulation of lysyl oxidase in the kidneys of hereditary nephrotic mouse with chronic renal fibrosis.

Authors:  Yasufumi Goto; Kozue Uchio-Yamada; Sayuri Anan; Yoshie Yamamoto; Atsuo Ogura; Noboru Manabe
Journal:  Virchows Arch       Date:  2005-08-05       Impact factor: 4.064

5.  Transglutaminase 2 and its role in pulmonary fibrosis.

Authors:  Keith C Olsen; Ramil E Sapinoro; R M Kottmann; Ajit A Kulkarni; Siiri E Iismaa; Gail V W Johnson; Thomas H Thatcher; Richard P Phipps; Patricia J Sime
Journal:  Am J Respir Crit Care Med       Date:  2011-06-23       Impact factor: 21.405

Review 6.  Substrates, inhibitors, and probes of mammalian transglutaminase 2.

Authors:  Ruize Zhuang; Chaitan Khosla
Journal:  Anal Biochem       Date:  2019-12-24       Impact factor: 3.365

7.  Tissue transglutaminase expression and activity in normal and glaucomatous human trabecular meshwork cells and tissues.

Authors:  Tara Tovar-Vidales; Rouel Roque; Abbot F Clark; Robert J Wordinger
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-02       Impact factor: 4.799

8.  Heparan sulfate proteoglycans are receptors for the cell-surface trafficking and biological activity of transglutaminase-2.

Authors:  Alessandra Scarpellini; Renée Germack; Hugues Lortat-Jacob; Takashi Muramatsu; Ellen Billett; Timothy Johnson; Elisabetta A M Verderio
Journal:  J Biol Chem       Date:  2009-04-27       Impact factor: 5.157

9.  Fibronectin-tissue transglutaminase matrix rescues RGD-impaired cell adhesion through syndecan-4 and beta1 integrin co-signaling.

Authors:  Dilek Telci; Zhuo Wang; Xiaoling Li; Elisabetta A M Verderio; Martin J Humphries; Manuela Baccarini; Huveyda Basaga; Martin Griffin
Journal:  J Biol Chem       Date:  2008-05-22       Impact factor: 5.157

10.  Increased TG2 expression can result in induction of transforming growth factor beta1, causing increased synthesis and deposition of matrix proteins, which can be regulated by nitric oxide.

Authors:  Dilek Telci; Russell John Collighan; Huveyda Basaga; Martin Griffin
Journal:  J Biol Chem       Date:  2009-08-05       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.